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The concept of improving animal health through improved gut health has existed in food 
animal production for decades; however, only recently have we had the tools to identify 
microbes in the intestine associated with improved performance. Currently, little is known 
about how the avian microbiome develops or the factors that affect its composition. To 
begin to address this knowledge gap, the present study assessed the development of 
the cecal microbiome in chicks from hatch to 28 days of age with and without a live 
Salmonella vaccine and/or probiotic supplement; both are products intended to promote 
gut health. The microbiome of growing chicks develops rapidly from days 1–3, and the 
microbiome is primarily Enterobacteriaceae, but Firmicutes increase in abundance and 
taxonomic diversity starting around day 7. As the microbiome continues to develop, the 
influence of the treatments becomes stronger. Predicted metagenomic content suggests 
that, functionally, treatment may stimulate more differences at day 14, despite the strong 
taxonomic differences at day 28. These results demonstrate that these live microbial 
treatments do impact the development of the bacterial taxa found in the growing chicks; 
however, additional experiments are needed to understand the biochemical and func-
tional consequences of these alterations.
Keywords: chicken, microbiome development, Salmonella, probiotic, gut development
inTrODUcTiOn
Increasing evidence in multiple species demonstrate the impact gut microbes have on intestinal 
function, digestion, host metabolism, and immune function (1, 2). While the food animal industry 
has employed various methods to control and augment the bacteria in the gut for decades, this 
has been done with little understanding of the complexity of the microbial populations and their 
association with animal health. The advent of microbiome analysis will allow for better use of these 
Abbreviations: ANOSIM, analysis of similarity; DC, diluent-control; DP, diluent-probiotic; FDR, false discovery rate; KEGG, 
Kyoto Encyclopedia of Genes and Genomes; MANOVA, multivariate analysis of variance; OTU, operational taxonomic 
unit; PERMANOVA, Permutational MANOVA; PICRUSt, phylogenetic investigation of communities by reconstruction of 
unobserved states; PCoA, principal coordinate analysis; QIIME, quantitative insights into microbial ecology; ST, Salmonella 
Typhimurium; SIMPER, similarity percentage analysis; STAMP, statistical analysis of metagenomics profiles; VC, vaccine-
control; VP, vaccine-probiotic.
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products and the rational design of new therapies to promote 
animal health and performance. An estimated $585 million/
year is spent globally on interventions to manage disease 
in food animals (3); many of these diseases are intestinal 
in nature (4), and the indirect costs of these intestinal dis-
eases are far greater. The application of modern nucleotide 
sequencing and associated bioinformatics techniques to the 
avian gastrointestinal microbiome will lead to breakthroughs 
in our understanding of digestive processes, host metabolic 
regulation, immune function, and intestinal dysfunction and 
pathology. Collectively, increased understanding of the host–
microbiome relationship, and the development of techniques 
to improve these interactions, could reduce the prevalence of 
food-borne pathogens. In order to effectively apply modern 
microbial ecology research techniques and elucidate the man-
ner in which the avian intestinal microbiome interacts with 
the host genome, it is imperative to develop a comprehensive 
understanding of how the avian microbiome develops under 
different physiological states and management practices.
There is a dearth of information available on the devel-
opment and definition of a normal avian gut microbiome. 
Recent investigations have begun to identify species com-
monly seen in adult chickens, but little is known about the 
intermediate and developing community (5–7). Furthermore, 
there is a paucity of information of the effects of treatments 
that target the gut environment on the development of the 
intestinal microbiome of chickens. This impairs our ability to 
understand how these gut-targeted treatments interact with 
each other and the host, and how they might affect gut activ-
ity and health. A better understanding of these interactions 
will allow for the rational use of bacterial groups to promote 
specific host responses.
The goal of this study was to understand the ontogeny of 
the chicken intestinal microbiome, and how commonly used 
live bacterial treatments influence this dynamic microbial 
community. Specifically, we included two live bacterial 
products currently used in the industry that are intended 
to improve animal health through manipulation of the host 
microbiota. We used a live attenuated Salmonella enterica, 
serovar Typhimurium vaccine (Salmune®, CEVA Biomune), 
and a probiotic feed supplement comprised of Lactobacillus 
acidophilus, Lactobacillus casei, Enterococcus faecium, and 
Bifidobacterium bifidum(PrimaLac®, Star Labs). We hypoth-
esized that the species richness of the microbiome would 
increase rapidly, and the addition of live bacterial treatments 
would alter the development of microbial diversity and the 
composition of the microbiome. The results from this study 
demonstrated exposing developing chickens to individual 
or combined bacterial regimens leads to treatment-specific 
microbial populations. These populations continue to diverge 
with age, even in animals receiving only a one-time dose of 
the Salmonella Typhimurium (ST) vaccine at day of hatch. 
Predicted metagenomic content in these populations sug-
gest changes in potential microbial metabolic activity and 
microbe-derived signaling molecules; however, these changes 




Two hundred one-day-old female commercial white leghorn lay-
ing type chickens (W-36, Hy-line International) were assigned to 
one of four treatments (50 chicks/treatment) in a 2 × 2 factorial 
design. The four groups were designated as follows: Diluent-
Control (DC); Diluent-Probiotic (DP); Vaccine-Control (VC); 
and Vaccine-Probiotic (VP). Animals received either a one-time 
dose of a live, attenuated ST spray vaccine (Salmune®, Ceva 
Biomune, Lenexa, KS; Vaccine group) or a sham vaccination 
consisting of the vaccine diluent, water (Diluent group). The vac-
cine and diluent spray were administered as recommended by the 
manufacturer. These treatment groups were further divided into 
two dietary groups; one group (Control) was fed a standard corn–
soybean starter diet (Table S1 in Supplementary Material) and the 
probiotic group was fed an identical starter diet supplemented 
with 0.1% (w/w) of the probiotic PrimaLac® (L. acidophilus, L. 
casei, E. faecium, B. bifidum; Star Labs Inc., Clarksdale, MO, USA; 
Probiotic group). Probiotic pre-mix was added to the probiotic 
groups’ feed prior to the experiment and animals in all groups 
were fed ad libitum for 4 weeks.
Animals in all groups were housed in 934-1-WP isolators (L. 
H. Leathers Inc., Athens GA) climate-controlled HEPA-filtered 
isolation units. The animals were maintained and euthanized 
under an approved protocol from the North Carolina State 
University Institutional Animal Care and Use Committee (OLAW 
#A3331-01).
sample collection
Six chickens from each treatment group were euthanized (CO2 
followed by cervical dislocation) on days 0, 1, 3, 7, 14, and 28 
and the contents of one cecal lobe collected and maintained on 
ice. At early timepoints, some chicks yielded minimal or no cecal 
digesta; these are noted in Table S2 in Supplementary Material. 
The cecal samples were weighed and diluted with 600 μl of 30% 
glycerol in PBS for storage at −80°C.
Dna isolation and 16s sequencing
DNA was isolated from each cecal sample using the MO BIO 
Power Soil kit (MO BIO, Carlsbad, CA, USA) with the following 
modifications: a 10-min, 65°C incubation step was added and 
samples were then homogenized for 45  s at 5100 RPM using 
garnet bead-containing tubes and a Precellys 24 homogenizer 
(Precellys, Montigny-le-Bretonneux, France).
DNA recovered from the extraction process was quanti-
fied using a NanoDrop 2000 spectrophotometer (NanoDrop, 
Wilmington, DE, USA) and 10  ng from each sample were 
aliquoted into 96-well plates in a random order. Some animals 
contained only small amounts of cecal digesta, particularly at 
days 0–3, resulting in very small amounts of DNA for some 
samples. DNA from these samples was included in the sequenc-
ing process, despite the possibility of poor quality sequencing 
(Table S2 in Supplementary Material). MiSeq library prepara-
tion and 151  ×  151 paired-end sequencing (Illumina, San 
Diego, CA, USA) were performed by the Argonne National 
Laboratory Institute for Genomics and Systems Biology Next 
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Generation Sequencing Core using a protocol and primers rec-
ommended and previously described by the Earth Microbiome 
project and others. Primers used spanned the V4 region of 
the 16S rRNA gene (515F: GTGYCAGCMGCCGCGGTAA, 
806R: GGACTACHVGGGTWTCTAAT) (8). This primer set 
is commonly used to evaluate the microbiome community 
across a variety of fields, and is well validated in several 
models, including the chicken (8–11). Studies estimating 
microbial composition using V4 sequence information report 
diversity measurements comparable to those obtained with 
full-length 16S sequences (12).
sequence Data analysis
The unpaired raw sequencing reads were paired and filtered using 
EA-Utils (13). Paired reads were processed using the QIIME suite 
of tools (v 1.8.0) (14); barcode matching and quality filtering were 
conducted prior to picking operational taxonomic units (OTUs). 
The 16S sequencing process did not yield equal sequence coverage 
for all samples, and some samples had very low sequence cover-
age. Samples with low sequence coverage or consistently poor 
quality were excluded from analysis. Additionally, some ceca 
from early time points contained little to no recoverable digesta. 
Consequently, a small number of samples from different time 
points were removed at this stage (Table S2 in Supplementary 
Material). OTUs were picked using an open-reference proto-
col. Briefly, sequences were grouped into OTUs based on 97% 
sequence identity using uclust and the Greengenes reference 
database (15, 16). OTUs that failed to match to the database were 
reclustered, resampled, and re-compared to the database; in this 
way, new reference sequences are compared to the database in 
order to minimize the number of excluded sequences. Finally, 
OTUs that failed to align to any sequences in the reference 
database are de novo clustered. Representative sequences from 
each OTU were picked and assigned taxonomy using the uclust 
consensus taxonomy assigner. During this process, sequences 
with high identity (>97%) were grouped into the same OTU, and 
are reported at the lowest level of taxonomic identification com-
mon to all sequences (17, 18). Sequence coverage was normalized 
across samples in each analysis. Taxonomic assignments, and 
alpha and beta diversity metrics were generated using QIIME 
and Primer-E (v6.1.16; Primer-E LTD, Ivybridge, UK). Principal 
coordinate analysis (PCoA) plots used in this study were gener-
ated in Primer-E using the Bray–Curtis distance metric (19).
Permutational multivariate analysis of variance 
(PERMANOVA) was conducted using the PERMANOVA+ add-
on to Primer-E. Main and pair-wise tests were conducted using 
up to 1000 permutations of residuals under a reduced model. 
Similarity percentage analysis (SIMPER) of taxonomic groups 
between treatment groups and times was made in Primer-E using 
Bray–Curtis distances. Analysis of similarity (ANOSIM) tests 
were conducted using Primer-E. Tests were conducted using up 
to 1000 permutations and the Spearman rank correlation method. 
A global test statistic (R) was generated for each treatment; the 
rank similarities between and within treatments were calculated 
and compared. The global R statistic is a measure of the strength 
of a treatment group’s association with microbiome composition, 
with 1 being the strongest association and 0 being no association.
Metagenomic inferences from the 16S amplicon data were 
made using the QIIME suite of tools (14, 15, 17, 18), PICRUSt 
(20), and KEGG (21); statistics and visualization of functional 
data were depicted using STAMP (22). Closed-reference 
OTU-picking protocols were used to identify 16S sequences 
belonging to annotated genomes. Briefly, sequences were 
grouped into OTUs based on 97% sequence identity using 
uclust and the Greengenes reference database. Representative 
sequences from each OTU were picked and assigned taxonomy 
using the uclust consensus taxonomy assigner. PICRUSt and 
KEGG were used to generate a list of functional genes pre-
dicted to be present in the sample and to organize these genes 
into gene pathways. Using STAMP, heatmaps were generated 
displaying differences in gene-group abundance at each time 
point. In order to minimize the number of treatment-based 
differences that may not be biologically relevant, analysis was 
limited to those differences with an effect size greater than 0.7 
as calculated by STAMP (eta-squared method) (22). Storey’s 
FDR correction was applied to all comparisons between treat-
ments (23). Nearest neighbor hierarchical clustering was used 
to group each sample according to abundance of gene groups 
in question.
resUlTs
Microbiome composition and complexity 
change rapidly with age
16S rRNA sequence analysis of the microbiome from the ceca of 
untreated animals (DC) demonstrated a microbiome with low 
diversity in days 0 and 1, dominated by Enterobacteriaceae and 
to a lesser extent Enterococcus (Figure 1). The number of OTUs 
detected in the microbiome increased significantly (P <  0.05) 
by day 3 (data not shown). This increase in bacterial richness 
starts with Ruminococcaceae groups during the first week of life 
and continues with other Firmicutes. By day 14, and extending 
through day 28, Ruminococcus and other Firmicutes outnumber 
Enterobacteriaceae (Figure 1).
age More influential in Microbiome 
Development than Treatment
Principal coordinate analysis of samples across all time points 
and treatment groups reveals that the effect of animal age 
on community composition was larger than that of bacterial 
treatment (Figure  2A). The ANOSIM-generated global test 
statistics for time (R  =  0.67) and the treatments (Vaccine 
R  =  0.361, Probiotic R  =  0.317) demonstrate the relative 
impact of each on the community. At time points 0–7, the 
samples show large within time point variability. At day 28, 
within time point variability is decreased and samples are 
tightly clustered in the PCoA plot (Figure 2A). Community 
analysis of cecal samples across time points and treatment 
groups show that Gram-negative bacteria (Proteobacteria) 
dominate at early time points, while Gram-positive Firmicutes, 
especially Clostridia taxa, become more prominent with age 
(Figure 2B).
FigUre 1 | as the cecal microbiome develops, the dominant taxa shift from gram-negative to gram-positive bacteria. A heatmap of taxonomic groups 
present in untreated (DC) samples over time was generated with Qiime. The composition of the microbiome in DC animals was evaluated to identify trends in the 
development of the normal microbiome over time. There is a consistent decrease in the proportion of Enterobacteriaceae and Enterococcus over time, and an 
increase in levels of Clostridiales groups like Ruminococcus and Oscillospira. Sequence coverage was normalized to 16,260 reads/sample.
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Treatments alter Microbial composition 
and rate of Development
Analyses of microbial populations were conducted within each 
time point (days 1, 7, 14, and 28) to assess the impact of treatment 
on composition and richness of the microbiome independent of 
age. No differences in microbial composition were detected at 
day 1, but significant differences in cecal microbiome composi-
tion were observed among all four treatment groups by day 7 
(Figure  3A). A PERMANOVA showed that all four treatment 
groups are distinct in composition at days 7, 14, and 28 (P < 0.05). 
A comparison of taxonomic richness (alpha diversity) among 
treatment groups at days 1, 7, 14, and 28 was made using rarefac-
tion plots. The treatment groups show similar levels of unique 
taxa at day 1; however, at days 7 and 14, probiotic groups tend 
to have fewer unique taxa (P < 0.1 at day 7, P < 0.05 at day 14). 
Interestingly, there was no significant difference in alpha diversity 
at day 28 (Figure 3B).
Treatment with live Bacteria affects 
abundance of Taxa not associated With 
Treatment
Similarity percentage analysis conducted between treatment 
groups at days 14 and 28 indicates that the differences between 
treatment groups can largely be attributed to changes in the 
most abundant order, Clostridiales, including Lachnospiraceae 
and Ruminococcaceae genera (Tables  1 and 2). MANOVA was 
used to identify differentially abundant taxa between treatment 
groups, with an FDR correction made to account for multiple 
comparisons. At day 14, DC animals harbored a significantly 
higher proportion of Enterobacteriaceae (Table  1) with 16% 
Enterobacteriaceae as compared to 3–9% in the other treat-
ments. Lactobacillus was significantly increased in the DP group 
relative to DC. At day 14, 83% of significantly different taxa were 
Firmicutes, and 63% were Clostridia.
Analysis of the taxonomic groups represented in each treat-
ment at day 28 indicate that most significant changes occur in 
the Firmicutes phylum, including differences in the abundance 
of Ruminococcaceae, Lachnospiraceae, and Peptostreptococcaceae 
(Table 2). Lactobacillus is also increased in the DP group relative 
to DC. Eighty-one percent of all significantly different taxa at day 
28 were in the Order Clostridiales.
Treatment-induced changes in 
Microbiome Diversity lead to Predicted 
changes in abundance of Functional gene 
Families
Estimates were made of the functional changes that may 
occur in the cecal microbiome following treatment using 
FigUre 2 | age is the dominant factor in the composition of the microbiome. (a) Principal coordinate analysis of samples was conducted using Primer-E 
and samples were labeled based on age. Samples are clustered on two axes based on a multi-dimensional analysis of their sequence diversity and abundance. As 
the animals age, their microbiome increases in complexity but decreases in variability between samples, even between treatment groups. The effect of age was 
stronger than the effect of vaccine or probiotic. Differences between all time points were significant at permutational P-value <0.05, with the exception of day 0 vs. 
days 1 and 3. Coordinate loading for each principal coordinate shows the primary taxonomic groups contributing to each axis. Each data point represents a sample 
in the appropriate time point, and samples from all treatment groups are included in the analysis. (B) The phylum and class of sequences with an average relative 
abundance of 1% or greater are displayed by time point and treatment. All treatment groups started with high levels of Gammaproteobacteria that shifted with age 
into a Firmicutes-dominated community with large numbers of Clostridia. Taxonomy assignments were generated with QIIME, and PCoA plots were generated with 
Primer-E. Sequence coverage was normalized to 16,260 reads/sample.
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closed-reference OTU-picking and PICRUSt. Gene groups 
targeted for statistical analysis had an FDR-corrected P < 0.01, 
and an effect size of 0.7 or higher. At day 14, samples cluster 
primarily by probiotic treatment, and the VP group is most 
distinct from other treatments. The combination of ST and 
probiotic treatments increases the expected proportion of 
genes related to environment-sensing; two-component sys-
tems, bacterial motility, chemotaxis, and flagellar component 
assembly genes were predicted to increase. DC, DP, and VC 
groups have relatively higher abundance of genes related to 
amino acid metabolism, DNA repair and replication, and 
translation (Figure 4A). The differences between DC, DP, and 
VC groups were minor, but the DP group displayed the lowest 
expected abundance of two-component system and bacterial 
motility genes.
Fewer gene groups met the inclusion criteria at day 28, and the 
total relative abundance of included gene groups was lower than 
that at day 14. At day 28, DP and VP treatment groups display 
higher predicted levels of genes related to one carbon metabolism, 
terpenoid synthesis, and translation proteins (Figure  4B). DC 
and DP groups had higher proportions of fatty acid metabolism, 
drug metabolism, and signal transduction gene pathways.
Relative abundance tables of taxa and predicted gene groups 
were used to generate area charts of between-treatment changes 
FigUre 3 | Principal coordinate analysis and rarefaction analyses demonstrate the impact of the treatments over time. (a) Principal coordinate analysis 
generated with Primer-E demonstrates the effect of treatments at 1, 7, 14, and 28 days of age. There are no significant treatment differences at day 1. By day 7, 
treatment groups are statistically different based on PERMANOVA tests. Treatment groups cluster visually at days 14 and 28. All treatment groups at days 7, 14, and 
28 were different at permutational P < 0.05. (B) Rarefaction of observed species (unique OTUs) at individual time points was conducted using QIIME, and 
demonstrate the rapid development of taxonomic diversity. Treatment groups show similar diversity at Day 1. At day 7, DP and VP tend to have lower diversity than 
VC (P = 0.078 and 0.054, respectively). At day 14, DP and VP diversity is significantly lower than DC and VC diversity (P < 0.05). By day 28, community diversity is 
similar between treatments. Sequence coverage was normalized for each time point individually: day 1 (16,577 reads/sample), day 7 (16,668 reads/sample), day 14 
(20,263 reads/sample), and day 28 (20,263 reads/sample).
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TaBle 2 | similarity percentage analysis (siMPer) of treatment groups at day 28a.
Phylum class Order Family genus average abundance (%) % contribution to 
dissimilarityb
Dc DP
Firmicutes Clostridia Clostridiales Lachnospiraceae Ruminococcusc 12 19 16.65
Firmicutes Clostridia Clostridiales Ruminococcaceae 11 18* 12.94
Firmicutes Clostridia Clostridiales Other Otherd 11 5* 9.57
Firmicutes Clostridia Clostridiales Ruminococcaceae Oscillospira 12 8* 9.22
Firmicutes Clostridia Erysipelotrichales Erysipelotrichaceae 2 5 7.73
Dc Vc
Firmicutes Clostridia Clostridiales 12 21* 15.41
Firmicutes Clostridia Clostridiales Lachnospiraceae 15 10* 13.49
Firmicutes Clostridia Clostridiales Other Other 11 4* 12.26
Firmicutes Clostridia Clostridiales Ruminococcaceae Ruminococcus 5 9 7.53
Firmicutes Clostridia Clostridiales Lachnospiraceae Ruminococcus 12 12 7.45
Dc VP
Firmicutes Clostridia Clostridiales 12 36* 32.27
Firmicutes Clostridia Clostridiales Lachnospiraceae 15 5* 14.03
Firmicutes Clostridia Clostridiales Other Other 11 1* 13.05
Firmicutes Clostridia Clostridiales Ruminococcaceae 11 16* 6.85
Firmicutes Clostridia Clostridiales Lachnospiraceae Ruminococcus 12 11 5.11
aTop 5 taxa shown for each comparison.
bPercent contribution to total dissimilarity between treatment groups under comparison.
cIf a sequence matches more than one possible taxon, classification stops at the next highest level.
d“Other” indicates the sequence in question has not been assigned to a taxonomic group at that level.
*Indicates significance at P ≤ 0.05.
TaBle 1 | similarity percentage analysis (siMPer) of treatment groups at day 14a.
Phylum class Order Family genus average  
abundance (%)
% contribution to 
dissimilarityb
Dc DP
Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus 1 16* 19.4
Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceaec 16 3* 15.65
Firmicutes Clostridia Clostridiales Lachnospiraceae Ruminococcus 25 26 15.27
Firmicutes Clostridia Clostridiales Ruminococcaceae 19 14* 9.01
Firmicutes Clostridia Clostridiales Ruminococcaceae Oscillospira 11 15 8.58
Dc Vc
Firmicutes Clostridia Clostridiales Lachnospiraceae 8 16* 15.4
Firmicutes Clostridia Clostridiales 4 12* 14.57
Firmicutes Clostridia Clostridiales Ruminococcaceae 19 13* 13.61
Firmicutes Clostridia Clostridiales Lachnospiraceae Ruminococcus 25 24 13.28
Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae 16 9* 13.12
Dc VP
Firmicutes Clostridia Clostridiales Lachnospiraceae 8 39* 25.58
Firmicutes Clostridia Clostridiales Lachnospiraceae Ruminococcus 25 2* 18.69
Firmicutes Clostridia Clostridiales Ruminococcaceae 19 3* 13.46
Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae 16 5* 9.07
Firmicutes Clostridia Clostridiales 4 14* 8.95
aTop 5 taxa shown for each comparison.
bPercent contribution to total dissimilarity between treatment groups under comparison.
cIf a sequence matches more than one possible taxon, classification stops at the next highest level.
*Indicates significance at P ≤ 0.05.
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in taxa and gene groups. Vaccine and Probiotic groups differ 
from the DC group taxonomically at both days 14 and 28. 
Gene-group abundance shows less treatment-specific variability 
(Figure 5).
DiscUssiOn
Little is known about the development of the microbiome in 
young birds, and how it is affected by different stimuli (7). The 
FigUre 4 | at both days 14 and 28, the VP group shows the greatest divergence in predicted metagenomic content. PICRUSt was used to generate a 
list of genes inferred to be present in the samples, their relative abundance, and the gene pathways with which they are associated. A heatmap was generated with 
STAMP. Samples were clustered using a nearest neighbor metric, and pathways were colored based on their percent abundance relative to all measured genes. All 
listed gene groups are significantly different between treatment groups with an effect size >0.70 and FDR-corrected P < 0.01. The combination of vaccine and 
probiotic treatments stimulates changes in several gene groups and pathways at day 14 (a), namely increases in chemotaxis, two-component system, flagellar 
assembly, and bacterial motility. Decreases in the VP group include metabolic processes, such as amino acid metabolism, DNA replication, and protein translation. 
(B) There are fewer significantly different pathways at day 28 and changes are largely related to cell metabolism.
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FigUre 5 | comparison of taxonomic and gene-group abundance trends at days 14 and 28. Relative abundance of taxonomic groups and predicted 
abundance of functional gene groups demonstrate the stability of gene-group abundances relative to changes in taxonomic groups. Relative abundance tables for 
taxa and gene group were assembled and used to generate area charts of all samples at days 14 and 28. The relative abundance of every identified taxonomic or 
functional gene group is shown for each sample; (a) predicted gene groups at day 14, (B) taxonomic groups at day 14, (c) predicted gene groups at day 28, (D) 
taxonomic groups at day 28. At day 14, there are clear taxonomic differences between treatments (a), and smaller changes in the abundance of a few gene groups 
(B). At day 28, taxonomic changes (D) are accompanied by few visible changes in gene-group abundance (c).
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goal of this study was to characterize the healthy developing 
microbiome in chickens and understand how commonly used 
bacterial treatments intended to improve or maintain health 
would affect this process. This is important in the food animal 
industry as there are numerous feed additives intended to improve 
animal health, either directly or indirectly through improving gut 
health. However, the mechanisms by which these amendments 
work are poorly understood. Most claim to enhance health and 
performance via manipulation of the host intestinal microbiome, 
but the mechanism of action has been studied in very few of these 
products (24, 25).
In the present study, we administered two commonly used live 
bacterial treatments applied in poultry production to enhance 
intestinal health and function. According to the manufacturer, 
the live ST vaccine used here is intended to prevent colonization 
of the gut and internal organs by multiple types of Salmonella, 
including Heidelberg, Typhimurium, Hadar, Kentucky, and 
Enteritidis (26). Similarly, the probiotic used here is intended to 
maintain healthy microbiota balance in the gut (27). We investi-
gated to what extent these health-promoting treatments affect the 
microbiome of young chicks.
We found that the post-hatch intestinal microbiome has low 
diversity dominated by Gram-negative bacteria, particularly 
Enterobacteriaceae, which includes Salmonella, Klebsiella, Proteus, 
and Escherichia coli. During the first week of life, there is a shift 
to a much more diverse community comprised of a wide variety 
of Gram-positive bacteria, mainly within the Clostridiales group, 
resulting in a correspondingly smaller proportion of Gram-
negative bacteria (Figure 1). The proportion of Gram-negative 
bacteria in the cecum at day 28 is <6%, and it is almost entirely 
Enterobacteriaceae.
Data from the present study suggest a microbiome more 
affected by age than treatment (Figure  2A). Irrespective of 
treatment, all groups show a sharp decline in Enterobacteriaceae 
with age, including the vaccinated groups, where levels of 
Enterobacteriaceae would be expected to increase following 
Salmonella (member of the Enterobacteriaceae family) vaccina-
tion. Nor does addition of a Firmicutes-based probiotic product 
stimulate more rapid conversion to a Firmicutes-dominated 
microbiome (Figure 2B) in probiotic-fed animals. Day-old birds 
begin with a gut colonized by few bacterial species at a concen-
tration several orders of magnitude lower than mature animals 
(28, 29), so it is likely that the primary driver of age-dependent 
increase in complexity is bacteria colonizing a previously empty 
niche. However, diet can also play a major role in the composition 
of the microbiome and exerts an influence on the developing and 
mature gut (30, 31). Studies by Sergeant et al. characterizing the 
microbiome of wheat-fed chickens reported Megamonas and 
Negativicutes as more abundant in their adult birds, while the 
Firmicutes most commonly seen in this trial, Lachnospiraceae 
and Ruminococcaceae, were less abundant (32). The effect of gut 
development on the intestinal microbiome is more difficult to 
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quantify; though studies of germ free and gnotobiotic mice clearly 
demonstrate that the microbiome is essential to the development 
of a fully functioning gut (33, 34), whether the developmental 
stage of the gut is a variable influencing the development of the 
microbiome is less clear.
Despite the strong relationship between age and composi-
tion of the microbiome, the bacterial treatments included 
in this study did affect the microbiome. PCoA of the four 
treatment groups at days 1, 7, 14, and 28 illustrate the impact 
of both vaccination and probiotic supplementation on the 
microbiome (Figure  3A). Despite the fact that the vaccine is 
only administered on day 0, global R statistics demonstrate 
that the impact of ST on the composition of the microbiome 
is on par with that of the continuously fed probiotic at days 14 
(vaccine = 0.802, probiotic = 0.882) and 28 (vaccine = 0.697, 
probiotic = 0.705). The magnitude of the effect of the one-time 
ST inoculation is nearly as great as that of the continuously 
fed probiotic despite low levels of the ST-containing taxonomic 
group Enterobacteriaceae after day 7, suggesting early coloniz-
ers influence the relative abundance of the microbiome despite 
being transient themselves. While little is known about the 
long-term effects of early microbiome perturbation, some stud-
ies support this idea (35, 36).
To understand the impact of treatment at the taxonomic 
level, SIMPER was conducted to identify species contributing 
to differences between treated and untreated animals. Most 
of the differences between DC and treated animals at days 14 
and 28 involve Lachnospiraceae, Ruminococcaceae, and other 
Clostridiales (Tables 1 and 2). Though abundance of Lactobacillus 
in the DP and VP groups is higher at day 14 (P <  0.05), the 
magnitude of the increase in VP over DC is not great enough for 
Lactobacillus to be a major source of dissimilarity. There is little 
microbiological evidence that the bacterial products applied in 
this study interfere with each other; levels of Lactobacillus are not 
significantly lower in the VP group than the DP group, and VP 
animals remain ST-positive at day 28 (data not shown). There are 
signs of treatment interaction; however, ST vaccination decreases 
abundance of the group Clostridiales Other, and the combination 
of probiotic and vaccine results in the strongest difference from 
the DP group; 11% reduced to 1% of the identified bacteria, 
perhaps indicating a synergy between the two treatments, which 
makes the cecum a more hostile environment for this group of 
bacteria.
Changes in taxonomic diversity are the most used indicator 
to infer changes in microbiological activity, but it is becoming 
apparent that many of the functions of a normal microbiome can 
be carried out by a number of microbial groups (37, 38). Therefore, 
understanding how treatments affect taxonomic abundance may 
not provide us with a complete understanding of how they impact 
healthy and diseased guts, or develop therapies that target the 
predominant cause of gut dysbiosis; a change in function. In its 
entirety, the chicken gut is estimated to be colonized by as many as 
1013 microbes, and they have a combined genetic potential far in 
excess of the ~20,000 genes identified in the chicken genome (39, 
40). PICRUSt uses the 16S rRNA genes obtained during sequenc-
ing to infer the presence of functional genes known or predicted 
to be associated with those 16S sequences. At day 14, there were 
predicted increases in the VP group in genes related to motility, 
flagellar assembly, chemotaxis, and two-component system. By 
contrast, VP microbiomes displayed lower abundance of many 
protein and energy metabolism genes, as well as genes related to 
DNA replication and protein translation (Figure 4A). Supporting 
the taxonomic data suggesting that the microbiome is still equili-
brating at day 14 (Figures 2 and 3), the functional changes at day 
28 are both fewer and less dramatic (Figure 5). The VP group 
exhibits the most variation of the four treatments, and suggests 
changes in a few cellular metabolism pathways. Interestingly, the 
effect of probiotic supplementation and its interaction with the 
vaccine appears to stimulate more functional changes than the 
vaccine group alone. At days 14 and 28, the DP and VP groups 
were more likely to have either the highest or lowest levels of any 
given gene group.
A possible contributor to the lack of more dramatic functional 
diversity between treatment groups at day 28 could be limitations 
inherent to this technique and its application to avian microbial 
communities. One of these is its reliance on sequenced and anno-
tated genomes. Though comparisons between PICRUSt results 
and metagenomics data from the same samples have shown that 
the predictive value of PICRUSt analysis is very good (20, 41), 16S 
genes without a confident phylogenetic assignment cannot be used 
as marker genes. Because of this, about 15% of the 16S sequences 
were filtered out at day 14 and over 20% at day 28. This number 
of unknown or uncharacterized sequences may be higher in the 
avian microbiome than in the human or murine microbiome, as 
the databases used in this process were all developed based on 
mammalian microbiota; chicken-specific microbes that may be 
important in this system could be excluded from analysis because 
they are not part of the 16s and/or KEGG databases. However, 
this analytical technique has been successfully used on avian 
microbiomes in the past (6). While the difference in excluded taxa 
between time points is not large, it is possible that the bacteria 
excluded from analysis are active in the community; evaluation 
of those taxa excluded from PICRUSt analysis indicates that some 
are differentially abundant between treatment groups (Tables S3 
and S4 in Supplementary Material). These bacteria could play a 
significant role in the activity of the microbiome. Bacteria falling 
under the Clostridiales Other group were consistently higher in 
the DC group relative to other treatments, and could represent 
an unmeasured source of functional differences between treat-
ment groups. However, their metagenomic contribution to the 
community cannot be known without further characterization 
of their genome.
The relative lack of functional gene differences at day 28 could 
also be an indication that despite continuing taxonomic differ-
ences, the microbiome in each treatment is converging toward a 
similar metabolic pattern. Conservation of function across a vari-
ety of microbial profiles has been described in other studies, and 
extreme dysregulation of the microbiome may be required before 
severe or protracted functional changes occur (37). Figure  5 
illustrates this concept; while the bacterial treatments applied in 
this study affect both the taxonomic and inferred metagenomic 
composition of the microbiome, even statistically significant 
changes in function gene content are minor when compared to 
the taxonomic changes seen in the same animals.
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In the present study, the chickens were all free of visible 
disease or stress, and it is possible their gut microbiota were 
functioning in their optimal range with or without treatment. 
It is also important to note that these birds were not given a 
pathogen challenge or other stressor of any kind. The addition 
of vaccinations or probiotics to a chicken with a dysbiotic gut 
microbiome might yield more significant functional changes. 
Recent studies demonstrated that exposure of mice to antibiotics 
at an early age can have a deleterious effect on the diversity of the 
microbiome for several months following treatment (42). This 
study showed no such effect from probiotic or vaccination. The 
value of select dietary treatments and management practices in 
poultry production may be their ability to increase the speed at 
which a disturbed or stunted microbiome is able to return to a 
normal functional state.
In conclusion, one-time oral inoculation with a live ST strain 
and daily ingestion of a probiotic feed supplement both alter 
the microbiome of growing chicks. These differences persisted 
throughout the study, and are centered on changes in the abun-
dance of core microbes present in all treatment groups. The results 
of this trial suggest that common bacterial treatments, such as 
probiotics and bacterial vaccines, affect the taxonomic composi-
tion of the microbiome, but only have transient or small effects on 
the function and activity of the microbiome under non-stressed 
growth conditions. By contrast, as has been seen in other studies 
(7), age played a major role in the composition and richness of 
the bacterial community. Major shifts from day of hatch to day 14 
centered on the early dominance of Enterobacteriaceae, followed 
by a transition to Firmicutes-dominated ceca. Future studies will 
focus on understanding the functional and phylogenetic param-
eters of a normal developing microbiome, and to evaluate the 
effect of treatments like these on that normal range of microbial 
profiles.
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